Levetiracetam Zentiva

Levetiracetam, the active ingredient in Levetiracetam Zentiva, is an anticonvulsant presented as a tablet for oral use. It is used to treat various seizure types in patients with epilepsy. GNH USA supplies Levetiracetam Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic medication that acts on neuronal excitability to control seizure activity. - Partial seizures: reduces the frequency and severity of focal onset seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes. - Myoclonic seizures: diminishes sudden muscle jerks associated with this seizure type.

Levetiracetam may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: sensation of light‑headedness or unsteadiness. - Headache: mild to moderate cranial pain. - Irritability: increased mood swings or agitation. - Nausea: upset stomach or feeling of queasiness. - Nasal congestion: blocked or runny nose.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood changes: depression, suicidal thoughts, or aggressive behavior. - Blood disorders: signs of anemia or low white blood cell count. - Liver dysfunction: jaundice or abnormal liver enzyme levels. - Skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before initiating therapy, consider the following safety measures. - Renal function: adjust dose in patients with impaired kidney function. - Psychiatric history: monitor for mood alterations or suicidal ideation. - Pregnancy: discuss potential risks with a healthcare professional. - Breastfeeding: evaluate benefits versus potential infant exposure. - Concomitant CNS depressants: use caution as additive sedation may occur. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Levetiracetam can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Valproic acid: potential for increased adverse effects. - Fluconazole: may modestly raise levetiracetam concentrations. - Oral contraceptives: monitor for reduced contraceptive effectiveness. - Other antiepileptics: assess for additive CNS depression. - Alcohol: may enhance drowsiness and dizziness.